Tag: deep brain stimulation

flow depression

Medication-free treatment for depression launches in the UK

Flow launches a medication-free treatment for depression comprising a brain stimulation headset and therapy app. In Europe, Flow is classified as a Class IIa...

Review shows inaccuracies of deep brain stimulation data for minimally conscious...

Results from a systematic review reveal that evidence for the use of deep brain stimulation (DBS) of various targets to promote recovery in patients...

International Neuromodulation Society announces 14th World Congress

The International Neuromodulation Society (INS) will hold its 14th World Congress from May 25–30, 2019 in Sydney, Australia. The multidisciplinary meeting highlights top international...

New data show the therapeutic benefits of directional leads for use...

The PROGRESS study has achieved its primary endpoint and demonstrated superiority of the therapeutic window using Abbott directional stimulation compared to omnidirectional stimulation. Results...

Abbott receives CE mark of MR-conditional labelling for Infinity deep brain...

Parkinson’s disease, dystonia and essential tremor patients in CE Mark countries will now benefit from upgraded functionality and new magnetic resonance (MR) conditional labelling...

Deep brain stimulation found to yield “robust but limited” clinical benefits...

A recent study evaluating the efficacy of deep brain stimulation (DBS) in patients with disorders of consciousness reported that robust but limited clinical benefits—predominantly...

Deep brain stimulation associated with a decreased risk of fall in...

Chronic subthalamic deep brain stimulation (DBS) is associated with a decreased risk for recurrent falls and delays the onset of psychosis in patients with...

Deep brain stimulation showing promise for patients with mild Alzheimer’s disease...

An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most...

Positive late-breaking data from the INTREPID study announced

The one-year data from the INTREPID study, the first and only prospective, double-blind, randomised, sham-controlled, multi-centre study of deep brain stimulation (DBS) for advanced,...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Deep brain stimulation shows promise as treatment for Alzheimer’s disease

Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and...

Vercise deep brain stimulation system gains FDA approval

The US Food and Drug Administration (FDA) has approved the Vercise deep brain stimulation (DBS) system (Boston Scientific). DBS is used to treat the symptoms...

Aleva Neurotherapeutics raises US$13 million in latest financing round

Aleva Neurotherapeutics has raised US$13 million in a Series D financing round. The round was led by Forrestal Capital, a fund with specific experience...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

DBS for chronic neuropathic pain efficacious at three years’ follow-up

A study published in the journal Neuromodulation has shown efficacy at three years’ follow-up for deep brain stimulation (DBS) for the treatment of neuropathic...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

SureTune3 earns CE mark for deep brain stimulation therapy

CE mark has been granted to the SureTune3 software (Medtronic) for deep brain stimulation (DBS). SureTune3 provides patient-specific visualisation of lead location and simulated...

Parkinson’s disease patients first to be treated with Leksell Vantage Stereotactic...

The Leksell Vantage Stereotactic system (Elekta) is now in clinical use at three European centres. The first surgeries were performed on a patient with...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

CE mark for Vercise Gevia deep brain stimulation system

CE mark has been granted for the Vercise Gevia deep brain stimulation (DBS) system (Boston Scientific), a rechargeable, magnetic resonance (MR) conditional device indicated...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

SureTune3 deep brain stimulation software receives Health Canada licence

Medtronic has received a Health Canada licence for SureTune3 software for deep brain stimulation (DBS). The latest innovations in the SureTune technology are designed...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Deep brain stimulation decreases tics in young adults with severe Tourette...

Deep brain stimulation therapy reduces the “tics,” or involuntary movements and vocal outbursts, experienced by young adults with severe cases of Tourette syndrome, according to...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Deep brain stimulation treatment for chronic anorexia is safe and may...

Deep brain stimulation might alter the brain circuits that drive anorexia nervosa symptoms and help improve patients’ mental and physical health, according to a...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

Spinal cord stimulation leads to “significant improvement” in gait in Parkinson’s...

A recent study explores the safety and efficacy of spinal cord stimulation on gait disturbance in advanced Parkinson’s disease. The investigators found that spinal...

Infinity deep brain stimulation system approved in the USA

St Jude Medical has announced the United States Food and Drug Administration approval and first implant of the Infinity deep brain stimulation (DBS) system...

Study finds deep brain stimulation a cost-effective treatment method for Parkinson’s...

It has been established that deep brain stimulation is clinically superior to medical therapy for treating advanced Parkinson’s disease. Jan B Pietzsch (Department of...

Medtronic’s StealthStation cranial software receives FDA clearance as an aid for...

Medtronic has announced US Food and Drug Administration (FDA) clearance of StealthStation cranial software as an aid for deep brain stimulation (DBS) lead placement....

CE mark granted to Medtronic for SureTune2 deep brain stimulation therapy

Medtronic has received CE mark for SureTune2 software, which is designed to provide patient-specific visualisation to help physicians make decisions on how to program...

St Jude Medical launches Infinity deep brain stimulation system and directional...

St Jude Medical has launched the Infinity deep brain stimulation (DBS) system and directional DBS lead in Europe. The system, which received CE mark approval...

Medtronic announces European approval of the first and only full-body MR...

The expanded approval for full-body MRI scans applies to all patients receiving a new system and to an estimated 13,000 people in Europe already receiving Medtronic DBS therapy.